Skip to content
Screener

Keros Therapeutics KROS Q2 2026 earnings

Reported August 3, 2026 · After market close

EPS-$1.45Miss by $0.11
Revenue estimate$807.1K
EPS estimate-$1.34

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$14.8M
EPS estimate-$0.96

FAQ

When did Keros Therapeutics report Q2 2026 earnings?
Keros Therapeutics (KROS) reported Q2 2026 earnings on August 3, 2026 after market close.
What were Keros Therapeutics's Q2 2026 revenue and EPS?
Keros Therapeutics reported eps of $-1.45 for Q2 2026.
Did Keros Therapeutics beat estimates in Q2 2026?
EPS missed the consensus estimate of $-1.34 by $0.11.
How did Keros Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 90.8% from $-0.76.
Where can I find Keros Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001664710-26-000048) and the 10-Q periodic report (0001664710-26-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.